Blue Line Capital’s Oracle ORCL Stock Holding History

Blue Line Capital’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Buy	10,473 +935	+10%	+$169K	1.28%	26
2026 Q1	$1.4M	Buy	9,538 +4,063	+74%	+$660K	1.59%	28
2025 Q4	$1.07M	Buy	+5,475	New	+$1.3M	1.26%	26

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Blue Line Capital's ORCL Position: Q2 2026 in Review

Blue Line Capital increased its Oracle (ORCL) stake by 9.8% in Q2 2026, buying an estimated $169K and bringing the position to 10,473 shares worth $1.53M. The position accounts for 1.28% of the portfolio, ranked #26.

Blue Line Capital first reported a position in ORCL in Q4 2025 and has held it in 3 quarters since. 3,511 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Blue Line Capital held 10,473 shares of Oracle worth $1.53M as of Q2 2026.
Blue Line Capital bought 935 Oracle shares in Q2 2026, an estimated $169K.
Oracle made up 1.28% of Blue Line Capital's portfolio in Q2 2026, its #26 holding.
Blue Line Capital first reported a position in Oracle in Q4 2025 and has held it in 3 quarters since.
3,511 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Blue Line Capital's 13F filing for Q2 2026, filed 30 Jul 2026.